Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71


Augmentation of T cell levels and responses induced by androgen deprivation.

Roden AC, Moser MT, Tri SD, Mercader M, Kuntz SM, Dong H, Hurwitz AA, McKean DJ, Celis E, Leibovich BC, Allison JP, Kwon ED.

J Immunol. 2004 Nov 15;173(10):6098-108.


Normal T-cell development and immune functions in TRIM-deficient mice.

Kölsch U, Arndt B, Reinhold D, Lindquist JA, Jüling N, Kliche S, Pfeffer K, Bruyns E, Schraven B, Simeoni L.

Mol Cell Biol. 2006 May;26(9):3639-48.


Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.

Maile R, Siler CA, Kerry SE, Midkiff KE, Collins EJ, Frelinger JA.

J Immunol. 2005 Jan 15;174(2):619-27.


CD28 in thymocyte development and peripheral T cell activation in mice exposed to suspended particulate matter.

Drela N, Ześko I, Jakubowska M, Biernacka M.

Toxicol Appl Pharmacol. 2006 Sep 1;215(2):179-88. Epub 2006 Mar 31.


CD18 is required for intestinal T cell responses at multiple immune checkpoints.

Marski M, Ye AL, Abraham C.

J Immunol. 2007 Feb 15;178(4):2104-12.


IgE enhances antibody and T cell responses in vivo via CD23+ B cells.

Getahun A, Hjelm F, Heyman B.

J Immunol. 2005 Aug 1;175(3):1473-82.


Regional oral tolerance in transgenic 2C mice.

Margenthaler JA, Flye MW.

Surgery. 2005 Aug;138(2):141-9.


Is there a role for cellular prion protein in intrathymic T cell differentiation and migration?

Terra-Granado E, Berbert LR, de Meis J, Nomizo R, Martins VR, Savino W, Silva-Barbosa SD.

Neuroimmunomodulation. 2007;14(3-4):213-9. Epub 2007 Dec 5.


Activation and migration of allo-peptide specific TCR transgenic T cells in cardiac allograft rejection.

Honjo K, Xu XY, Kapp JA, Bucy RP.

Cell Immunol. 2004 Jul;230(1):44-55.


Role of CD28 in polyclonal and specific T and B cell responses required for protection against blood stage malaria.

Elias RM, Sardinha LR, Bastos KR, Zago CA, da Silva AP, Alvarez JM, Lima MR.

J Immunol. 2005 Jan 15;174(2):790-9.


Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.

Li Q, Grover AC, Donald EJ, Carr A, Yu J, Whitfield J, Nelson M, Takeshita N, Chang AE.

J Immunol. 2005 Aug 1;175(3):1424-32.


Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2(-/-)gammac(-/-) mice.

Legrand N, Cupedo T, van Lent AU, Ebeli MJ, Weijer K, Hanke T, Spits H.

Blood. 2006 Jul 1;108(1):238-45. Epub 2006 Mar 2.


Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.

Markiewicz MA, Carayannopoulos LN, Naidenko OV, Matsui K, Burack WR, Wise EL, Fremont DH, Allen PM, Yokoyama WM, Colonna M, Shaw AS.

J Immunol. 2005 Sep 1;175(5):2825-33.


Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.

Bracci L, Moschella F, Sestili P, La Sorsa V, Valentini M, Canini I, Baccarini S, Maccari S, Ramoni C, Belardelli F, Proietti E.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):644-53.


Cutting edge: monovalency of CD28 maintains the antigen dependence of T cell costimulatory responses.

Dennehy KM, Elias F, Zeder-Lutz G, Ding X, Altschuh D, Lühder F, Hünig T.

J Immunol. 2006 May 15;176(10):5725-9.


The role of TCR specificity and clonal competition during reconstruction of the peripheral T cell pool.

Leitão C, Freitas AA, Garcia S.

J Immunol. 2009 May 1;182(9):5232-9. doi: 10.4049/jimmunol.0804071.


Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity.

Wong SC, Tan AH, Lam KP.

Cell Immunol. 2009;256(1-2):64-71. doi: 10.1016/j.cellimm.2009.01.009. Epub 2009 Feb 27.


Supplemental Content

Support Center